全覆膜自膨式金属支架治疗乳头括约肌切开术后出血的有效性与安全性:系统评价与Meta分析
该系统评价与Meta分析纳入7项研究共224例患者,评估全覆膜自膨式金属支架(FCSEMS)治疗乳头括约肌切开术后出血的有效性与安全性。汇总临床成功率为95%(95%CI 89-98),再出血率7%(95%CI 4-12),不良事件率6%(95%CI 2-16),胰腺炎率7%(95%CI 2-19),支架移位率10%(95%CI 5-20)。多数研究中FCSEMS作为常规内镜治疗失败后的补救治疗。
要点
- FCSEMS治疗乳头括约肌切开术后出血的汇总临床成功率为95%(95%CI 89-98)。
- 汇总再出血率为7%(95%CI 4-12),支架移位率为10%(95%CI 5-20)。
- 汇总不良事件率为6%(95%CI 2-16),胰腺炎率为7%(95%CI 2-19)。
核心结论
- 该Meta分析显示FCSEMS治疗乳头括约肌切开术后出血具有汇总的有效性与安全性,尤其作为常规内镜治疗后持续出血患者的补救治疗。
研究设计与样本
- 系统评价与Meta分析,检索多个数据库自建库至2024年11月6日,纳入7项研究共224例患者,采用随机效应模型计算汇总率及95%CI。
主要发现
- 汇总临床成功率为95%(95%CI 89-98)。
- 汇总再出血率为7%(95%CI 4-12)。
- 汇总不良事件率为6%(95%CI 2-16)。
- 汇总胰腺炎率为7%(95%CI 2-19)。
- 汇总支架移位率为10%(95%CI 5-20)。
关键数值与推荐
- 多数研究中FCSEMS在常规内镜治疗失败后使用,仅2项研究中部分患者作为初始治疗、部分作为常规治疗失败后的补救治疗。
临床怎么用
- 原文结论指出FCSEMS尤其可作为常规内镜治疗后持续出血患者的补救治疗。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND AIMS: Fully covered self-expandable metal stents (FCSEMSs) are often used in the management of postsphincterotomy bleeding that is refractory to conventional endoscopic treatments. In this meta-analysis, we evaluated the efficacy and safety of FCSEMSs in the management of postsphincterotomy bleeding. METHODS: We reviewed several databases from inception to November 6, 2024 to identify studies that evaluated the efficacy and/or safety of FCSEMSs in the management of postsphincterotomy bleeding. Our outcomes of interest were clinical success, recurrent bleeding, adverse events, stent migration, and pancreatitis. Subgroup analyses were performed by including studies in which FCSEMSs were used as a rescue treatment after failure of conventional endoscopic treatments. We calculated pooled rates with 95% confidence intervals (CIs) for our outcomes of interest. Data were analyzed using a random-effects model. RESULTS: We included 7 studies with 224 patients. Pooled rates of clinical success were 95% (95% CI, 89-98), of recurrent bleeding were 7% (95% CI, 4-12), and of adverse events were 6% (95% CI, 2-16). Pooled rates of pancreatitis were 7% (95% CI, 2-19) and of stent migration were 10% (95% CI, 5-20). In most studies, FCSEMSs were used after failure of conventional endoscopic treatments, except in 2 studies in which FCSEMSs were used in some patients for primary treatment and in others after failure of conventional endoscopic treatments CONCLUSIONS: Our meta-analysis demonstrates the pooled efficacy and safety of FCSEMSs in the management of postsphincterotomy bleeding, especially as a rescue treatment in patients with persistent bleeding after conventional endoscopic treatments.
引用
- Saeed A, Yousuf S, Gangwani MK, et al. Efficacy and safety of fully covered self-expandable metal stents in the management of postsphincterotomy bleeding: systematic review and meta-analysis. Gastrointest Endosc. 2024. PMID: 39716535. doi:10.1016/j.gie.2024.12.023
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。